BMP2 promotes lung adenocarcinoma metastasis through BMP receptor 2-mediated SMAD1/5 activation

Abstract Bone morphogenetic protein 2 (BMP2) is highly overexpressed in human non-small cell lung cancer (NSCLC) and correlates with tumor stage and metastatic burden. Although several lines of evidence suggest that BMP2 promotes cell migration and invasiveness in vitro, the in vivo role of BMP2 in...

Full description

Bibliographic Details
Main Authors: Cheng-Kuei Wu, Man-Ting Wei, Hung-Chang Wu, Cheng-Lin Wu, Cheng-Ju Wu, Hungjiun Liaw, Wen-Pin Su
Format: Article
Language:English
Published: Nature Portfolio 2022-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-20788-2
_version_ 1811202890964926464
author Cheng-Kuei Wu
Man-Ting Wei
Hung-Chang Wu
Cheng-Lin Wu
Cheng-Ju Wu
Hungjiun Liaw
Wen-Pin Su
author_facet Cheng-Kuei Wu
Man-Ting Wei
Hung-Chang Wu
Cheng-Lin Wu
Cheng-Ju Wu
Hungjiun Liaw
Wen-Pin Su
author_sort Cheng-Kuei Wu
collection DOAJ
description Abstract Bone morphogenetic protein 2 (BMP2) is highly overexpressed in human non-small cell lung cancer (NSCLC) and correlates with tumor stage and metastatic burden. Although several lines of evidence suggest that BMP2 promotes cell migration and invasiveness in vitro, the in vivo role of BMP2 in the metastasis of lung adenocarcinoma cells remains less well understood. Here, we revealed that BMP2 is highly overexpressed in lung adenocarcinoma patients with lymph node metastasis compared with patients without lymph node metastasis. Using an in vivo orthotopic mouse model, we clearly demonstrated that BMP2 promotes lung adenocarcinoma metastasis. The depletion of BMP2 or its receptor BMPR2 significantly reduced cell migration and invasiveness. We further identified that BMP2/BMPR2-mediated cell migration involves the activation of the SMAD1/5/8 signaling pathway, independent of the KRAS signaling pathway. Significantly, the depletion of SMAD1/5/8 or the inhibition of SMAD1/5/8 by LDN193189 inhibitor significantly reduced cell migration. These findings show that BMP2 promotes NSCLC metastasis, indicating that targeting the BMP2 signaling pathway may represent a potential therapeutic strategy for treating patients with metastatic NSCLC.
first_indexed 2024-04-12T02:45:30Z
format Article
id doaj.art-a606c2360b204f838d35f7a3cf0a21bd
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-12T02:45:30Z
publishDate 2022-09-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-a606c2360b204f838d35f7a3cf0a21bd2022-12-22T03:51:11ZengNature PortfolioScientific Reports2045-23222022-09-0112111310.1038/s41598-022-20788-2BMP2 promotes lung adenocarcinoma metastasis through BMP receptor 2-mediated SMAD1/5 activationCheng-Kuei Wu0Man-Ting Wei1Hung-Chang Wu2Cheng-Lin Wu3Cheng-Ju Wu4Hungjiun Liaw5Wen-Pin Su6Institute of Clinical Medicine, College of Medicine, National Cheng Kung UniversityInstitute of Clinical Medicine, College of Medicine, National Cheng Kung UniversityDivision of Hematology and Oncology, Department of Internal Medicine, Chi-Mei Medical CenterInstitute of Clinical Medicine, College of Medicine, National Cheng Kung UniversityDepartments of Oncology and Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung UniversityDepartment of Life Sciences, National Cheng Kung UniversityInstitute of Clinical Medicine, College of Medicine, National Cheng Kung UniversityAbstract Bone morphogenetic protein 2 (BMP2) is highly overexpressed in human non-small cell lung cancer (NSCLC) and correlates with tumor stage and metastatic burden. Although several lines of evidence suggest that BMP2 promotes cell migration and invasiveness in vitro, the in vivo role of BMP2 in the metastasis of lung adenocarcinoma cells remains less well understood. Here, we revealed that BMP2 is highly overexpressed in lung adenocarcinoma patients with lymph node metastasis compared with patients without lymph node metastasis. Using an in vivo orthotopic mouse model, we clearly demonstrated that BMP2 promotes lung adenocarcinoma metastasis. The depletion of BMP2 or its receptor BMPR2 significantly reduced cell migration and invasiveness. We further identified that BMP2/BMPR2-mediated cell migration involves the activation of the SMAD1/5/8 signaling pathway, independent of the KRAS signaling pathway. Significantly, the depletion of SMAD1/5/8 or the inhibition of SMAD1/5/8 by LDN193189 inhibitor significantly reduced cell migration. These findings show that BMP2 promotes NSCLC metastasis, indicating that targeting the BMP2 signaling pathway may represent a potential therapeutic strategy for treating patients with metastatic NSCLC.https://doi.org/10.1038/s41598-022-20788-2
spellingShingle Cheng-Kuei Wu
Man-Ting Wei
Hung-Chang Wu
Cheng-Lin Wu
Cheng-Ju Wu
Hungjiun Liaw
Wen-Pin Su
BMP2 promotes lung adenocarcinoma metastasis through BMP receptor 2-mediated SMAD1/5 activation
Scientific Reports
title BMP2 promotes lung adenocarcinoma metastasis through BMP receptor 2-mediated SMAD1/5 activation
title_full BMP2 promotes lung adenocarcinoma metastasis through BMP receptor 2-mediated SMAD1/5 activation
title_fullStr BMP2 promotes lung adenocarcinoma metastasis through BMP receptor 2-mediated SMAD1/5 activation
title_full_unstemmed BMP2 promotes lung adenocarcinoma metastasis through BMP receptor 2-mediated SMAD1/5 activation
title_short BMP2 promotes lung adenocarcinoma metastasis through BMP receptor 2-mediated SMAD1/5 activation
title_sort bmp2 promotes lung adenocarcinoma metastasis through bmp receptor 2 mediated smad1 5 activation
url https://doi.org/10.1038/s41598-022-20788-2
work_keys_str_mv AT chengkueiwu bmp2promoteslungadenocarcinomametastasisthroughbmpreceptor2mediatedsmad15activation
AT mantingwei bmp2promoteslungadenocarcinomametastasisthroughbmpreceptor2mediatedsmad15activation
AT hungchangwu bmp2promoteslungadenocarcinomametastasisthroughbmpreceptor2mediatedsmad15activation
AT chenglinwu bmp2promoteslungadenocarcinomametastasisthroughbmpreceptor2mediatedsmad15activation
AT chengjuwu bmp2promoteslungadenocarcinomametastasisthroughbmpreceptor2mediatedsmad15activation
AT hungjiunliaw bmp2promoteslungadenocarcinomametastasisthroughbmpreceptor2mediatedsmad15activation
AT wenpinsu bmp2promoteslungadenocarcinomametastasisthroughbmpreceptor2mediatedsmad15activation